Company Microba Life Sciences Limited

Equities

MAP

AU0000209868

Healthcare Facilities & Services

Market Closed - Australian S.E. 01:53:18 2024-04-26 am EDT 5-day change 1st Jan Change
0.18 AUD +12.50% Intraday chart for Microba Life Sciences Limited -2.70% 0.00%

Business Summary

Microba Life Sciences Limited is an Australia-based precision microbiome company. The Company is engaged in the discovery and development of therapeutics for major chronic diseases and delivers gut microbiome testing services globally to researchers, clinicians, and consumers. It offers various platforms, such as Analysis, Discovery, and Therapeutic. Through its analysis and discovery platforms, it identifies microbiome-derived therapeutics and diagnostic tools to advance medicine. Through its Analysis Platform, it generates a global databank of microbiome samples and associated metadata to develop new health solutions. Its Discovery Platform enables partners to access this databank for the data-driven discovery of product opportunities. Its therapeutic platform is a repeatable platform for microbial therapeutic leads. It also offers a product portfolio of gastrointestinal, vaginal, oral, and urinary microbiome testing, together with a targeted set of evidence-based formulations.

Sales per Business

AUD in Million2022Weight2023Weight Delta
Testing Services
100.0 %
5 100.0 % 5 100.0 % +15.60%

Sales per region

AUD in Million2022Weight2023Weight Delta
Australia
58.3 %
3 55.9 % 3 58.3 % +20.59%
Europe
20.0 %
1 16.5 % 1 20.0 % +39.69%
United States
10.2 %
1 16.3 % 1 10.2 % -27.56%
United Arab Emirates
8.4 %
0 5.7 % 0 8.4 % +71.27%
New Zealand
3.0 %
0 5.5 % 0 3.0 % -36.96%
United Kingdom
0.0 %
0 0.0 % 0 0.0 % +78.87%
Singapore
0.0 %
-- 0 0.0 % -

Managers

Managers TitleAgeSince
Chief Executive Officer - -
Director of Finance/CFO - -
Chief Tech/Sci/R&D Officer - -
Chief Tech/Sci/R&D Officer - -
Corporate Officer/Principal - 22-04-05
Sales & Marketing - -
Corporate Officer/Principal - -
Corporate Secretary 61 -

Members of the board

Members of the board TitleAgeSince
Director/Board Member 61 21-03-17
Director/Board Member - 22-09-07
Director/Board Member 61 -
Chairman - -
Founder - -
Director/Board Member - -
Director/Board Member - -

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 447,851,977 258,633,813 ( 57.75 %) 0 57.75 %

Shareholders

NameEquities%Valuation
72,677,638 16.23 % 10 M $
Perennial Value Management Ltd.
14.80 %
66,271,358 14.80 % 9 M $
33,480,799 7.476 % 5 M $
Thorney Investment Group Australia Pty Ltd.
5.835 %
26,129,972 5.835 % 4 M $
Gene Tyson
4.046 %
18,119,211 4.046 % 2 M $
17,828,431 3.981 % 2 M $
17,178,431 3.836 % 2 M $
Alium Capital Management Pty Ltd.
3.546 %
15,879,203 3.546 % 2 M $
11,535,246 2.576 % 2 M $
4,500,000 1.005 % 616 500 $

Company contact information

Microba Life Sciences Ltd.

324 Queen Street

4000, Brisbane

+

http://microba.com
address Microba Life Sciences Limited(MAP)

Sales per Business

Sales per region

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
0.18 AUD
Average target price
0.38 AUD
Spread / Average Target
+111.11%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. MAP Stock
  4. Company Microba Life Sciences Limited